Johnson and Johnson(J&J) in association with BenevolentAI, are all set to release drugs that were developed with the use of Artificial Intelligence (AI) technology. The latter achieved this after acquiring London based Janssen, a business subsidiary of J&J that will use multiple drug candidates to treat dreaded diseases. It is a known fact that some […]
The post Johnson and Johnson to use Artificial Intelligence to develop drugs appeared first on Cybersecurity Insiders.
This article has been indexed from Cybersecurity Insiders
Read the original article:
